mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.039 |
0.2 |
mRNA |
AZD8055 |
GDSC1000 |
pan-cancer |
AAC |
0.04 |
0.2 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.2 |
mRNA |
KU-55933 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.2 |
mRNA |
Elesclomol |
GDSC1000 |
pan-cancer |
AAC |
0.04 |
0.2 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.2 |
mRNA |
VX-680 |
GDSC1000 |
pan-cancer |
AAC |
0.062 |
0.2 |